{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T07:56:22Z","timestamp":1758095782215,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ajg.2024.12.005","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T23:48:26Z","timestamp":1747266506000},"page":"195-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical efficacy of phenobarbital combined with ursodeoxycholic acid in the treatment of neonatal patients with cholestasis"],"prefix":"10.1016","volume":"26","author":[{"given":"Lin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2024.12.005_b0005","doi-asserted-by":"crossref","first-page":"1175231","DOI":"10.3389\/fped.2023.1175231","article-title":"Editorial: Infants with cholestasis","volume":"11","author":"Uchida","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ajg.2024.12.005_b0010","doi-asserted-by":"crossref","first-page":"e1499","DOI":"10.1002\/wsbm.1499","article-title":"Liver fibrosis: Pathophysiology and clinical implications","volume":"13","author":"Berumen","year":"2021","journal-title":"WIREs Mech Dis"},{"key":"10.1016\/j.ajg.2024.12.005_b0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1017\/9781108918978.009","article-title":"Medical and Nutritional Management of Cholestasis in Infants and Children","author":"Suchy","year":"2021","journal-title":"Liver Disease in Children"},{"key":"10.1016\/j.ajg.2024.12.005_b0020","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ajg.2024.12.005_b0025","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.4103\/sjg.sjg_112_21","article-title":"Cholestatic liver disease: Practice guidelines from the Saudi Association for the Study of Liver diseases and Transplantation","volume":"27","author":"Mawardi","year":"2021","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.ajg.2024.12.005_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.sempedsurg.2020.150945","article-title":"Recent developments in diagnostics and treatment of neonatal cholestasis","volume":"29","author":"Feldman","year":"2020","journal-title":"Semin Pediatr Surg"},{"key":"10.1016\/j.ajg.2024.12.005_b0035","first-page":"107","author":"Ning","year":"2016","journal-title":"Correlation analysis between four serum biomarkers of liver fibrosis and liver function in infants with cholestasis"},{"key":"10.1016\/j.ajg.2024.12.005_b0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.medcli.2020.03.013","article-title":"Efficacy of ursodeoxycholic acid combined with prednisolone and immunosuppressant triple therapy in the treatment of refractory primary biliary cholangitis","volume":"155","author":"Yao","year":"2020","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.ajg.2024.12.005_b0045","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/lt.25935","article-title":"Ursodeoxycholic Acid Decreases Incidence of Primary Biliary Cholangitis and Biliary Complications After Liver Transplantation: A Meta-Analysis","volume":"27","author":"Pedersen","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ajg.2024.12.005_b0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12519-021-00487-0","article-title":"Ursodeoxycholic acid prevention on cholestasis associated with total parenteral nutrition in preterm infants: a randomized trial","volume":"18","author":"Liu","year":"2022","journal-title":"World J Pediatr"},{"key":"10.1016\/j.ajg.2024.12.005_b0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.ajg.2024.12.005_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-021-01749-x","article-title":"Successful treatment of infantile oxysterol 7\u03b1-hydroxylase deficiency with oral chenodeoxycholic acid","volume":"21","author":"Tang","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ajg.2024.12.005_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116617","article-title":"A high-dose of ursodeoxycholic acid treatment alleviates liver inflammation by remodeling gut microbiota and bile acid profile in a mouse model of non-alcoholic steatohepatitis","volume":"174","author":"Li","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ajg.2024.12.005_b0070","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(19)31270-X","article-title":"Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy. (PITCHES) a randomised controlled trial","volume":"394","author":"Chappell","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ajg.2024.12.005_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.774884","article-title":"Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajg.2024.12.005_b0080","doi-asserted-by":"crossref","first-page":"e0228213","DOI":"10.1371\/journal.pone.0228213","article-title":"Perinatal outcomes of intrahepatic cholestasis during pregnancy: An 8-year case-control study","volume":"15","author":"Arthuis","year":"2020","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ajg.2024.12.005_b0085","doi-asserted-by":"crossref","first-page":"e819","DOI":"10.1542\/neo.22-12-e819","article-title":"Neonatal cholestasis: Updates on diagnostics, therapeutics, and prevention","volume":"22","author":"Feldman","year":"2021","journal-title":"NeoReviews"},{"key":"10.1016\/j.ajg.2024.12.005_b0090","doi-asserted-by":"crossref","first-page":"e0280691","DOI":"10.1371\/journal.pone.0280691","article-title":"Efficacy and safety of ursodeoxycholic acid in children with cholestasis: A systematic review and meta-analysis","volume":"18","author":"Huang","year":"2023","journal-title":"PLoS One"},{"journal-title":"Cholestasis in the Baby and Infant","year":"2019","author":"Gunaydin","key":"10.1016\/j.ajg.2024.12.005_b0095"},{"key":"10.1016\/j.ajg.2024.12.005_b0100","unstructured":"Silva ES. Neonatal Cholestasis: New Insights into Pathophysiology and Strategies to Improve Patients\u2019 Diagnosis and Prognosis - ProQuest. 2022. https:\/\/www.proquest.com\/openview\/7cb6258a3b6730cdaa8af01350d4f2e3\/1?pq-origsite=gscholar&cbl=2026366&diss=y. Accessed 26 Mar 2024."},{"key":"10.1016\/j.ajg.2024.12.005_b0105","doi-asserted-by":"crossref","DOI":"10.1515\/crpm-2017-0033","article-title":"Congenital intrahepatic portosystemic shunts: a potential cause for early-onset neonatal cholestasis","author":"Narang","year":"2018","journal-title":"Case Reports in Perinatal Medicine"},{"issue":"5","key":"10.1016\/j.ajg.2024.12.005_b0110","first-page":"1158","article-title":"Clinical and genetic features of neonatal intrahepatic cholestasis caused by citrin deficiency in northern China: A single-center analysis of 23 cases","volume":"37","author":"Liu","year":"2021","journal-title":"Journal of Clinical Hepatology"},{"key":"10.1016\/j.ajg.2024.12.005_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115550","article-title":"Promising traditional Chinese medicine for the treatment of cholestatic liver disease process (cholestasis, hepatitis, liver fibrosis, liver cirrhosis)","volume":"297","author":"Wei","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ajg.2024.12.005_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109104","article-title":"Phenobarbital in Status epilepticus \u2013 Rediscovery of an effective drug","volume":"141","author":"Trinka","year":"2023","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ajg.2024.12.005_b0125","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/1098612X211037431","article-title":"Evaluation of the effect of phenobarbital administration on the biochemistry profile, with a focus on serum liver values, in epileptic cats","volume":"24","author":"Hermans","year":"2022","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.ajg.2024.12.005_b0130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.5863\/1551-6776-27.6.545","article-title":"Effect of Phenobarbital on Elevated Direct Bilirubin Concentrations in Neonates and Infants in the Neonatal Intensive Care Unit","volume":"27","author":"Shin","year":"2022","journal-title":"The Journal of Pediatric Pharmacology and Therapeutics"},{"key":"10.1016\/j.ajg.2024.12.005_b0135","doi-asserted-by":"crossref","unstructured":"Chappell LC, Bell JL, Smith A, et al. Ursodeoxycholic acid to reduce adverse perinatal outcomes for intrahepatic cholestasis of pregnancy: the PITCHES RCT. Efficacy and Mechanism Evaluation. 2020;7(9;:1\u201342.","DOI":"10.3310\/eme07090"},{"key":"10.1016\/j.ajg.2024.12.005_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101490","article-title":"Gradual dosing of ursodeoxycholic acid in mothers with intrahepatic cholestasis of pregnancy may improve composite neonatal outcome","volume":"29","author":"Hamud","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.ajg.2024.12.005_b0145","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s10620-022-07654-x","article-title":"Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis","volume":"68","author":"Can\u00e7ado","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ajg.2024.12.005_b0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bcp.2019.06.009","article-title":"Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis","volume":"168","author":"Razori","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajg.2024.12.005_b0155","doi-asserted-by":"crossref","first-page":"108938","DOI":"10.1016\/j.biopha.2019.108938","article-title":"Therapeutic effects of curcumin and ursodexycholic acid on non-alcoholic fatty liver disease","volume":"115","author":"Gheibi","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ajg.2024.12.005_b0160","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s10620-008-0600-8","article-title":"Ursodeoxycholic acid in neonatal hepatitis and infantile paucity of intrahepatic bile ducts: Review of a historical cohort","volume":"54","author":"Kotb","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ajg.2024.12.005_b0165","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1515\/JPEM.1999.12.4.549","article-title":"Parenteral nutrition-associated cholestasis in preterm neonates: Evaluation of ursodeoxycholic acid treatment","volume":"12","author":"Levine","year":"1999","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.ajg.2024.12.005_b0170","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/hep.32777","article-title":"Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease","volume":"77","author":"Leung","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2024.12.005_b0175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1201\/9780367813888-19","article-title":"Cholestasis and Fibrogenesis","author":"Pinzani","year":"2020","journal-title":"The Pathophysiology of Biliary Epithelia"},{"key":"10.1016\/j.ajg.2024.12.005_b0180","first-page":"151","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression. Nature Reviews","volume":"18","author":"Kisseleva","year":"2020","journal-title":"Gastroenterology & Hepatology"},{"key":"10.1016\/j.ajg.2024.12.005_b0185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4254\/wjh.v12.i8.423","article-title":"Review: Pathogenesis of cholestatic liver diseases","volume":"12","author":"Yokoda","year":"2020","journal-title":"World J Hepatol"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197924001333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197924001333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T09:57:59Z","timestamp":1758016679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197924001333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1687197924001333"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2024.12.005","relation":{},"ISSN":["1687-1979"],"issn-type":[{"type":"print","value":"1687-1979"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical efficacy of phenobarbital combined with ursodeoxycholic acid in the treatment of neonatal patients with cholestasis","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2024.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Pan-Arab Association of Gastroenterology.","name":"copyright","label":"Copyright"}]}}